ArticleJournal of inflammation research2025
The Predictive Role of FGF21 in Acute Liver Injury Caused by Bacterial Infectious Diseases in Critical Care: A Retrospective Cohort Study.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute liver injury (ALI) is a common complication in critically ill patients and has been strongly associated with adverse clinical outcomes. Early detection and timely management of ALI in these patients are crucial for implementing effective therapeutic strategies to prevent disease progression and improve patient outcomes. Methods: In this study, 112 critically ill patients with bacterial infectious diseases were categorized into two groups based on the presence or absence of ALI within 24 hours of the intensive care unit (ICU) admission. Serum concentrations of fibroblast growth factor 21 (FGF21), interleukin(IL)-6, IL-22, IL-10, liver enzymes, hypersensitive C-reactive protein (hs-CRP), and D-Dimer (D2) were measured within 24 hours of ICU admission. Demographic and clinical data were recorded. Logistic regression analysis was performed to identify potentially predictive biomarkers for ALI. Receiver operating characteristic (ROC) curve analysis was employed to determine the optimal model for predicting ALI in critically ill patients. Results: Patients in the ALI group exhibited significantly higher serum levels of IL-6, IL-10, IL-22, FGF21, liver enzymes, lactic acid, procalcitonin, D2, APACHE II scores, shorter survival time and higher 28-day mortality compared to those in the non-ALI group. Logistic regression analysis indicated that age, gender, plasma D2, and serum levels of direct bilirubin (DBIL), IL-22 and FGF21 were valuable predictors of ALI among critically ill patients. ROC curve revealed that this predictive model achieved a high area under the curve of 0.885, demonstrating excellent discriminatory ability. Conclusion: Elevated levels of serum FGF21 in the early stages of critical illness may represent a promising novel biomarker for predicting ALI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.